Literature DB >> 6179377

Suppression of erythema nodosum by indomethacin.

Z Ubogy, R H Persellin.   

Abstract

Erythema nodosum (EN) can be a debilitating illness. Many treatment modalities have been suggested but none is universally effective. We describe three patients with severe EN secondary to streptococcal pharyngitis who were unresponsive to large doses of aspirin. Following the administration of indomethacin in doses of 100 to 150 mg per day, all three showed a dramatic response, with prompt resolution both of systemic symptoms and of local signs of inflammation. The lesions of EN involve the lower cutis, with inflammation of septae and fat lobules. It is likely, therefore, that the local liberation of fatty acids leads to increased prostaglandin synthesis which, in turn, is responsible for the intense inflammation. The impressive suppression of EN by indomethacin could be related to the inhibition of prostaglandin synthetase in the subcutaneous fatty tissues.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6179377

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  4 in total

Review 1.  Important cutaneous manifestations of inflammatory bowel disease.

Authors:  L B Trost; J K McDonnell
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

Review 2.  Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview.

Authors:  Kyla Pagani; Danitza Lukac; Aashni Bhukhan; Jean S McGee
Journal:  Am J Clin Dermatol       Date:  2022-04-20       Impact factor: 6.233

3.  Compression stockings as an effective treatment for erythema nodosum: Case series.

Authors:  K B Golisch; S P Gottesman; R J Segal
Journal:  Int J Womens Dermatol       Date:  2017-09-29

4.  Erythema nodosum as a cutaneous manifestation of COVID-19 infection.

Authors:  Philipp Suter; Blandine Mooser; Hoa Phong Pham Huu Thien
Journal:  BMJ Case Rep       Date:  2020-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.